London's Exogenous Surfactant Study for COVID19

NCT04375735 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

ARDS, Human
COVID-19

Interventions

DRUG: Bovine Lipid Extract Surfactant

Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Collaborators

[object Object]